F072 Hair Loss in Women
DESCRIPTION
This session will focus on providing both data and expert experience on the management of the common nonscarring and scarring types of hair loss in women. The clinical and biopsy findings that can help separate hair loss presenting in the central scalp (FPHL, LPP subtypes, and CCCA) as well as effective topical, systemic, and procedural treatments for each will be discussed. The challenges that pregnancy and breastfeeding create for treatment of alopecia areata and ways to handle them will be presented. A productive approach to evaluation and management of telogen effluvium will be shared.
LEARNING OBJECTIVES
Formulate a treatment plan for the various types of central hair loss based on clinical and scalp biopsy findings
Identify and utilize most effective topical, systemic, and procedural treatments in non-scarring and scarring alopecias
Manage the specific issues of treating common hair loss conditions in women at various periods of life
SCHEDULE
9:00 AM
Central Scalp Cicatricial Alopecia: Pattern Hair loss as a Spectator or Player
Elise A. Olsen, MD, FAAD
9:18 AM
Treatment of Female Pattern Hair Loss
9:36 AM
Update on FFA
Maryanne Makredes Senna, MD, FAAD
9:54 AM
CCCA: Clinical Recognition, Diagnostic Pearls, and Treatment Strategies
Valerie D. Callender, MD, FAAD
10:12 AM
Telogen Efffluvium: How I treat it
Jerry Shapiro, MD, FAAD
10:30 AM
Alopecia Areata Treatment in Women: Navigating Pregnancy, Breastfeeding, and Beyond
Paradi Mirmirani, MD, FAAD
DIRECTOR
Elise A. Olsen, MD, FAAD
Duke University
SPEAKERS
Valerie D. Callender, MD, FAAD
Founder & Medical Director, Callender Dermatology& Cosmetic Center, Howard University College of Medicine
Maryanne Makredes Senna, MD, FAAD
Paradi Mirmirani, MD, FAAD
The Permanente Medical Group/ University of California- San Francisco
Jerry Shapiro, MD, FAAD
Professor, Ronald O. Perelman Department of Dermatology, New York University, NY
DISCLOSURES
Valerie D. Callender, MD, FAAD
Aerolase – Advisory Board(Stock Options), Speaker/Faculty Education(Honoraria); Altree – Stockholder Private Company(Stock Options); Arcutis Biotherapeutics – Speaker(Honoraria); Beiersdorf, Inc. – Speaker(Honoraria); Callender Center for Clinical Research – Founder(No Compensation Received); Eli Lilly – Speaker/Faculty Education(Honoraria); Eli Lilly and Company – Investigator(Grants/Research Funding); Elsevier Inc. – Independent Contractor(Honoraria); Incyte – Investigator(Grants/Research Funding); Janssen Biotech – Investigator(Grants/Research Funding); L'Oreal USA Inc. – Consultant(Honoraria), Investigator(Honoraria); La Roche-Posay - L'Oreal Group – Advisory Board(Honoraria); Ortho Dermatologics – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Prollenium Medical Technologies – Investigator(Grants/Research Funding); Regeneron Pharmaceuticals Inc – Investigator(Grants/Research Funding); Restore Biologics – Advisory Board(Honoraria); Sinclair Pharma – Investigator(Grants/Research Funding); SkinCeuticals LLC – Advisory Board(Honoraria), Speaker(Honoraria); symatese – Investigator(Grants/Research Funding); TEOXANE Laboratories – Investigator(Grants/Research Funding); Unilever – Advisory Board(Honoraria); UpToDate – Other(Patent royalties or other compensation for Intellectual Property Rights); Veradermics – Advisory Board(Honoraria); VeraDermics Inc. – Investigator(Grants/Research Funding); WoltersKluwer Health – Independent Contractor(Patent royalties or other compensation for Intellectual Property Rights);
Maryanne Makredes Senna, MD, FAAD
AbbVie – Advisory Board(Fees); American Hair Research Society – Board of Directors(No Compensation Received); Cicatricial Alopecia Research Foundation – Board of Directors(No Compensation Received); CoreEvitas, LLC – Advisory Board(Fees), Investigator(Grants/Research Funding); Eli Lilly and Company – Advisory Board(Fees); GLife – Advisory Board(Stock Options); Inmagene – Investigator(Grants/Research Funding); Inmagene Biopharmaceuticals – Consultant (1099 relationship)(Fees); Kintor Pharmaceutical Limited – Consultant (1099 relationship)(Fees); L'Oreal USA Inc. – Consultant (1099 relationship)(Fees); Leo Pharma Inc – Investigator(Grants/Research Funding); Pfizer Inc. – Advisory Board(Fees), Speaker(Fees); Priovant Therapeutics – Advisory Board(Fees), Investigator(Grants/Research Funding); Q32 Bio Inc. – Investigator(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – Advisory Board(Fees); Veradermics – Advisory Board(Fees), Advisory Board(Stock);
Paradi Mirmirani, MD, FAAD
Amgen – Investigator(Grants/Research Funding); Canfield Scientific, Inc. – Independent Contractor(Fees); Cicatricial Alopecia Research Foundation – Advisory Board(No Compensation Received); Eli Lilly and Company – Investigator(Grants/Research Funding); Incyte Corporation – Investigator(Grants/Research Funding); L'Oreal Dermatological Beauty – Advisory Board(Fees); Pfizer Inc. – Investigator(Grants/Research Funding); Priovant Therapeutics – Consultant (1099 relationship)(Fees); Springer Science & Business Media – Other(Patent royalties or other compensation for Intellectual Property Rights); Sun Pharmaceutical Industries Ltd. – Investigator(Grants/Research Funding); Unilever – Advisory Board(Fees); UpToDate, Inc – Other(Patent royalties or other compensation for Intellectual Property Rights); VeraDermics Inc. – Advisory Board(Honoraria);
Elise A. Olsen, MD, FAAD
Absci – Advisory Board(Honoraria); Aranda Pharm Ltd – Consultant (1099 relationship)(Honoraria); Canfield Scientific, Inc. – Consultant(Honoraria); Cosmos S.I. – Advisory Board(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Honoraria); Taisho Pharmaceuticals Co., Ltd. – Consultant (1099 relationship)(Honoraria); United States Cutaneous Lymphoma Consortium – Other(Grants/Research Funding); UpToDate, Inc – Other(Honoraria); VeraDermics Inc. – Consultant (1099 relationship)(Honoraria);
Jerry Shapiro, MD, FAAD
30 Madison – Consultant (1099 relationship)(Stock Options); AbbVie – Consultant (1099 relationship)(Honoraria); Almirall – Consultant (1099 relationship)(Honoraria); DS Laboratories – Consultant (1099 relationship)(Honoraria); Eirion Therapeutics – Consultant (1099 relationship)(Stock Options); Eli Lilly – Advisory Board(Honoraria); Pfizer Inc. – Consultant (1099 relationship)(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Honoraria); Veradermics – Consultant (1099 relationship)(Fees), Stockholder Public Company(No Compensation Received);